Earnings call transcript: NewtekOne misses Q3 2026 estimates as shares slip after hours

NewtekOne reported Q3 2026 EPS of $0.34 versus $0.45 expected and revenue of $71.78 million versus $77.53 million expected; shares fell 2.36% after hours to $11.19. Record quarterly net interest income of $18.9 million rose 26% sequentially and 30% year over year, while deposits reached $2.6 billion and management reaffirmed 2026 EPS guidance of $1.70–$1.80. Credit concerns included C&I LA non-performers rising to $82 million from $46 million, and management cited elevated rates and inflation as headwinds.

Analysis

NEWT: The key issue is earnings quality, not the headline miss. A shift from loan-sale gains to retaining loans can build recurring interest income, but it also consumes balance-sheet capacity and leaves more credit exposure on the books. The larger non-performing C&I LA balance makes that trade-off less theoretical; management’s spread-and-collateral rationale is not a substitute for observed loss and recovery data.

The funding story is similarly mixed. Rapid deposit growth does not guarantee durable, low-cost funding: management acknowledged core-deposit cross-selling is lagging. If growth relies disproportionately on rate-sensitive balances, funding costs could blunt the reported NII momentum and weaken the economics of holding loans. The planned January 2027 securitization may release capacity, but its benefit depends on execution, pricing, retained exposure and capital treatment—not simply collateral volume.

Near term (days): after-hours weakness is a limited signal without volume confirmation. Over 1–3 months, the test is whether Q4 earnings bridge to guidance through NII and seasonal originations despite weaker gain-on-sale income. Over 6–18 months, credit seasoning, core-deposit mix and securitization economics matter more than management’s technology narrative. The claimed platform value is an unverified optionality, not yet a basis for underwriting a premium; IP written off the balance sheet does not establish realizable value.

Contrarian point: the market may be discounting a growing bank as a low-multiple lender, but cheapness versus tangible book alone can be a value trap if credit costs rise or the funding mix deteriorates.

Key Decisions for Investors

• No immediate post-print long: wait for the next results or interim credit disclosure to show whether the Q4 earnings step-up is delivered without deterioration in non-performers, charge-offs or reserve coverage. The upside case is recurring NII; the downside is earnings and book-value pressure from credit losses or higher funding costs.
• Set a conditional alert for a small long position only if management’s next update supports full-year guidance and shows core-deposit progress alongside stable credit metrics. Do not underwrite the discount to tangible book or dividend yield as a floor; there is no reliable price target from the supplied data.
• Track the January 2027 securitization as a catalyst, not a certainty: verify completed issuance, pricing/spread, retained interests and resulting capital ratios. A delay, materially unattractive economics, or continued balance-sheet growth constraints would weaken the recovery thesis.
• Falsifiers: a guidance cut or failure to bridge to guidance; further material deterioration in C&I LA non-performers or realized losses; rising deposit costs without offsetting asset yields; or securitization terms that fail to free meaningful capacity.